Publishing a small pre-earnings update, hopefully there would be no surprises later on. The stock price seems to be stabilizing around 10 USD. Sales for the Q should come above 63.4 Mil, or I would be unhappy :(
Key risks:
- Product quality issues, returns, complaints
- Not achieving revenue growth targets (60+ % CAGR until 2025)
- Decrease in projected long term margins
- New players entering the market
- Supply chain issue and commodity risks
- Underutilization of government funds
- Management fail - execution risk
Key strengths:
- Developed and tested products
-...
